These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4027620)

  • 21. Effects of anterior hypothalamic deafferentation and neonatal monosodium-L-glutamate treatment on pulsatile LH secretion in the castrated rat.
    Rose PA; Weick RF
    Neuroendocrinology; 1986; 43(1):12-7. PubMed ID: 3713986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal monosodium glutamate differentially alters two models of behavioral activity in conjunction with reduced hypothalamic endorphins.
    Katz RJ
    Physiol Behav; 1983 Aug; 31(2):147-51. PubMed ID: 6314404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity.
    Poon TK; Cameron DP
    Am J Physiol; 1978 May; 234(5):E532-4. PubMed ID: 645905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats.
    Corder R; Saudan P; Mazlan M; McLean C; Gaillard RC
    Neuroendocrinology; 1990 Jan; 51(1):85-92. PubMed ID: 2106092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of neonatal treatment with monosodium glutamate on vasopressin release during foot shock stress in the rat.
    Knepel W; Nutto D; Hertting G
    Life Sci; 1983 Oct; 33(17):1703-9. PubMed ID: 6314081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool.
    Nemeroff CB; Lipton MA; Kizer JS
    Dev Neurosci; 1978; 1(2):102-9. PubMed ID: 39735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia.
    Scallet AC; Olney JW
    Brain Res; 1986 May; 374(2):380-4. PubMed ID: 3459567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hypophysectomy on the sleep of neonatally monosodium glutamate-treated rats.
    Zhang JX; Valatx JL; Jouvet M
    Brain Res Bull; 1988 Dec; 21(6):897-903. PubMed ID: 3224283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation.
    Spinedi E; Johnston C; Negro-Vilar A
    Endocrinology; 1984 Jul; 115(1):267-72. PubMed ID: 6145582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary responsiveness to LHRH stimulation in hamsters treated neonatally with monosodium glutamate.
    Lamperti AA; Baldwin DM
    Neuroendocrinology; 1982 Mar; 34(3):169-74. PubMed ID: 6803180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of visual responsiveness in the lateral geniculate nucleus of rats treated with monosodium-L-glutamate.
    Groos G
    Neurosci Lett; 1981 Sep; 25(3):293-7. PubMed ID: 7290530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral administration of monosodium glutamate (MSG) on the hypothalamic arcuate region of rat and mouse: a histological assay.
    Semprini ME; Conti L; Ciofi-Luzzatto A; Mariani A
    Biomedicine; 1974 Oct; 21(10):398-403. PubMed ID: 4616735
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat.
    Conte-Devolx B; Giraud P; Castanas E; Boudouresque F; Orlando M; Gillioz P; Oliver C
    Neuroendocrinology; 1981; 33(4):207-11. PubMed ID: 6270587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monosodium glutamate affects the temporal characteristics of biochemical variables in Wistar rats.
    Manivasagam T; Subramanian P
    Pol J Pharmacol; 2004; 56(1):79-84. PubMed ID: 15047981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in immunoreactive somatostatin levels in hypothalamic and gastroenteropancreatic tissue as a consequence of neonatal treatment with monosodium glutamate.
    DePaolo LV; Steger RW
    Proc Soc Exp Biol Med; 1985 Mar; 178(3):419-25. PubMed ID: 2858103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monosodium glutamate disruption of behavioral and endocrine function in the female rat.
    Rodriguez-Sierra JF; Sridaran R; Blake CA
    Neuroendocrinology; 1980 Sep; 31(3):228-35. PubMed ID: 7413022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of pituitary GnRH receptors in immature rats treated with monosodium glutamate.
    Dalkin AC; Duncan JA; Regiani S; Marshall JC
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E126-31. PubMed ID: 2981479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MSG lesions decrease body mass of suckling-age rats by attenuating circadian decreases of energy expenditure.
    Schoelch C; Hübschle T; Schmidt I; Nuesslein-Hildesheim B
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E604-11. PubMed ID: 12169455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice.
    Dawson R; Lorden JF
    J Comp Physiol Psychol; 1981 Feb; 95(1):71-84. PubMed ID: 7217414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
    Bodnar RJ; Truesdell LS; Nilaver G
    Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.